High Tech Beteiligungen

High-Tech Beteiligungen is a German venture capital investment vehicle primarily associated with the High-Tech Gründerfonds (HTGF), one of Europe's most active seed-stage investors in the life sciences. The firm focuses on providing early-stage financing to innovative startups in biotechnology, medical technology, and healthcare IT, often serving as the initial institutional investor for high-potential scientific spin-offs. Its portfolio has included notable successes such as CureVac, Rigontec, and Cardior Pharmaceuticals, demonstrating a strong track record in identifying and nurturing breakthrough therapeutic platforms. Based in Bonn, Germany, High-Tech Beteiligungen plays a pivotal role in the European biotech ecosystem by bridging the gap between academic research and commercial drug development.